Conference Paper: In hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacy

File Download Links for fulltext
(May Require Subscription)
  • Find via
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleIn hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacy
AuthorsMarcellin, P
Chan, HLY
Lai, CL
Clio, M
Heathcote, I
Moon, YM
Chao, YC
Myers, R
Harb, G
Brown, NA
Issue Date2007
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
CitationJournal of Hepatology, v. 46 n. Suppl 1, p. S193 [How to Cite?]
ISSN0168-8278
2011 Impact Factor: 9.264
2011 SCImago Journal Rankings: 0.765
DC Field
Value
dc.contributor.authorMarcellin, P
dc.contributor.authorChan, HLY
dc.contributor.authorLai, CL
dc.contributor.authorClio, M
dc.contributor.authorHeathcote, I
dc.contributor.authorMoon, YM
dc.contributor.authorChao, YC
dc.contributor.authorMyers, R
dc.contributor.authorHarb, G
dc.contributor.authorBrown, NA
dc.date.accessioned2010-09-25T19:34:30Z
dc.date.available2010-09-25T19:34:30Z
dc.date.issued2007
dc.identifier.citationJournal of Hepatology, v. 46 n. Suppl 1, p. S193 [How to Cite?]
dc.identifier.hkuros152472
dc.identifier.issn0168-8278
2011 Impact Factor: 9.264
2011 SCImago Journal Rankings: 0.765
dc.identifier.issueSuppl 1
dc.identifier.openurl
dc.identifier.spage193
dc.identifier.urihttp://hdl.handle.net/10722/101063
dc.identifier.volume, v. 46 n. Suppl 1
dc.languageeng
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
dc.relation.ispartofJournal of Hepatology
dc.rightsJournal of Hepatology. Copyright © Elsevier BV.
dc.titleIn hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacy
dc.typeConference_Paper